Standard esophagectomy after neoadjuvant chemoradiation may provide greater long-term survival and quality-of-life benefits than active surveillance for most patients with esophageal cancer.
https://t.co/ydBON89RmH
Delving into the“Organ Preservation for Gastroesophageal Junction & Gastric Adenocarcinoma: Ready for Primetime?” w co-chairs Drs. Daniel Tandel Chang & Ugwuji Maduekwe @ #GI26. Case-based discussions w/ opposing views. 🔥 #esocsm https://t.co/Tsb21Xq0zF @Daniela_Molena@IkomaMD
Pleased to contribute to this study with colleagues from across Europe @stjamesdublin@CancerInstIRE - care for pts with major UGI emergency conditions remains an important aspect of our unit's work @nicraftery@BJSurgery https://t.co/r9aLlmy0I9
Patients who received robot-assisted surgery vs conventional laparoscopic surgery had a higher incidence of postoperative pulmonary complications and received longer and more intense mechanical ventilation.
https://t.co/dPqE8zqWHa
Robotic hiatal hernia repair offered no short-term morbidity or mortality advantage over laparoscopic hiatal hernia repair but incurred longer operative times and a higher pulmonary embolism risk in older adults. https://t.co/GUgUbJUpzo
🏥 Inaugurato il Nuovo Ospedale Pediatrico del Veneto “Salus Pueri”. Una struttura moderna, ispirata alla natura, che unisce cura, ricerca e formazione
https://t.co/ITMtginR9M
SANO trial: innovations, risks, and unanswered questions - felt very strongly along with several UGI colleagues we must highlight the important limitations of the SANO trial and thus counsel our patients appropriately regarding these results! https://t.co/A0SnM5fDDd
ESOPEC, a large randomized trial involving patients with resectable esophageal cancer, showed that perioperative chemotherapy improved overall survival as compared with preoperative chemoradiotherapy. Full trial results: https://t.co/QwTnBfB63q
Editorial: Multimodal Treatment in Locally Advanced Esophageal Adenocarcinoma — Two Interventions Better Than Three? https://t.co/bjvo4qd4ID
Steve showed us that the future isn’t something you wait for—it’s something you build. His memory lives on in the hearts of innovators and dreamers everywhere—at Apple and beyond.
I am pleased to inform you that the primary result of JCOG1109 was published in the Lancet today. The neoadjuvant triplet chemotherapy would be the standard care for the locally advanced ESCC. Many thanks to everyone involved. https://t.co/YvNAwbLdUO
Great work by @JamieTankel demonstrating that non-regional retroperitoneal nodes in gastro-esophageal adeno can be treated successfully with curative intent surgery in select cases. @JournalofGISurg @SSATNews https://t.co/xOvbm4ncJG
Abbiamo inaugurato l'802° a.a. #Unipd con la rettrice Mapelli, il ministro Carlo Nordio @minGiustizia, il direttore generale @ascuttari , la presidente del consiglio degli studenti Emma Ruzzon e la prolusione di Simone Montangero @DFAUnipd
> https://t.co/OybOczMYVc